Despite the anticipated FDA approval of the first MASH drug by the end of 2023, lifestyle interventions aiming at significant weight loss will remain cornerstone therapy for this disease. So far dietary interventions at large scale have failed to show sus

Recently, there has been increased interest in judicious use of IV albumin in patients with decompensated cirrhosis. On one hand, its use has been advocated as first line therapy for several indications. On the other hand, concerns about its unregulated u

There are known healthcare disparities within pediatric liver transplantation that impact access to care, listing, transplantation, and outcomes. This workshop is designed to discuss approaches and initiatives in patient advocacy to empower healthcare pro

MTE session on managing the patient with PSC when they become sick, have cholangitis, may have cancer, may need a transplant, are symptomatic, need a colectomy, just need help to stay out of hospital! Building the confidence of providers in managing compl

MTE focused on current and future approaches to second and third line treatment choices in patients living with PBC. Practical and relevant to many wanting an update on PBC

Approaches to management of portal hypertension in children remain controversial. This MTE will debate the pros and cons of treatment options in pediatric portal hypertension.

Liver disease and transplantation in children is a unique problem. Yet, pediatric patients are listed for liver transplant in almost the same way as adult patients; as a result, the severity of disease is not always accurately captured in kids. Living don

Mitochondria play critical roles in various types of cell death including apoptosis, necroptosis and ferroptosis. Mitochondria are dynamic organelles constantly undergo fission and fusion as well as biogenesis and removal by mitophagy.  We will discuss cu

Explain the use of COVID-19 vaccines in patients with liver disease and liver transplantation and discuss emerging data on other preventive strategies.

To review the logistical and financial aspects of running a high volume program using DCDs and machine perfusion.